T. Rowe Price Associates’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-14,850
| Closed | -$827K | – | 2605 |
|
|
2018
Q4 | $827K | Buy |
14,850
+168
| +1% | +$9.12K | ﹤0.01% | 1885 |
|
|
2018
Q3 | $682K | Buy |
14,682
+120
| +0.8% | +$5.81K | ﹤0.01% | 2021 |
|
|
2018
Q2 | $703K | Buy |
14,562
+122
| +0.8% | +$5.84K | ﹤0.01% | 1996 |
|
|
2018
Q1 | $625K | Buy |
14,440
+126
| +0.9% | +$5.66K | ﹤0.01% | 1995 |
|
|
2017
Q4 | $568K | Sell |
14,314
-1,580
| -10% | -$65.8K | ﹤0.01% | 2045 |
|
|
2017
Q3 | $690K | Hold |
15,894
| – | – | ﹤0.01% | 1951 |
|
|
2017
Q2 | $761K | Buy |
15,894
+14
| +0.1% | +$653 | ﹤0.01% | 1892 |
|
|
2017
Q1 | $652K | Hold |
15,880
| – | – | ﹤0.01% | 1963 |
|
|
2016
Q4 | $610K | Buy |
15,880
+10
| +0.1% | +$406 | ﹤0.01% | 1974 |
|
|
2016
Q3 | $852K | Buy |
15,870
+2,700
| +21% | +$125K | ﹤0.01% | 1801 |
|
|
2016
Q2 | $566K | Sell |
13,170
-1,157,645
| -99% | -$48.6M | ﹤0.01% | 1916 |
|
|
2016
Q1 | $59.1M | Buy |
1,170,815
+412,210
| +54% | +$19.8M | 0.01% | 712 |
|
|
2015
Q4 | $48M | Buy |
758,605
+28,890
| +4% | +$1.97M | 0.01% | 780 |
|
|
2015
Q3 | $47.8M | Sell |
729,715
-72,520
| -9% | -$4.81M | 0.01% | 781 |
|
|
2015
Q2 | $54.3M | Sell |
802,235
-304,545
| -28% | -$16.8M | 0.01% | 808 |
|
|
2015
Q1 | $47.3M | Buy |
1,106,780
+1,101,280
| +20,023% | +$49M | 0.01% | 862 |
|
|
2014
Q4 | $272K | Sell |
5,500
-4,000
| -42% | -$160K | ﹤0.01% | 2218 |
|
|
2014
Q3 | $273K | Buy |
+9,500
| New | +$258K | ﹤0.01% | 2188 |
|
|
2014
Q2 | – | Sell |
-4,700
| Closed | -$262K | – | 2559 |
|
|
2014
Q1 | $262K | Hold |
4,700
| – | – | ﹤0.01% | 2218 |
|
|
2013
Q4 | $226K | Buy |
+4,700
| New | +$198K | ﹤0.01% | 2272 |
|
T. Rowe Price Associates's IMPV Position: Q1 2019 in Review
T. Rowe Price Associates sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 14,850 shares — an estimated $827K sold.
T. Rowe Price Associates first reported a position in IMPV in Q4 2013 and held it in 20 quarters. The position peaked at $59.1M in Q1 2016. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- T. Rowe Price Associates reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- T. Rowe Price Associates sold 14,850 Imperva, Inc. shares in Q1 2019, an estimated $827K.
- T. Rowe Price Associates first reported a position in Imperva, Inc. in Q4 2013 and held it in 20 quarters.
- T. Rowe Price Associates's Imperva, Inc. position peaked at $59.1M in Q1 2016.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.